An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: A pilot study

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Mallia, Patrick ^a   Message, Simon D ^a   Kebadze, Tatiana ^a   Parker, Hayley L ^a   Kon, Onn M ^b   Johnston, Sebastian L ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMON COLD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; EXPERIMENTAL INFECTION; FEASIBILITY STUDY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN RHINOVIRUS; LOWER RESPIRATORY TRACT; LUNG FUNCTION; NOSE MUCUS; OUTCOMES RESEARCH; PATIENT SAFETY; PEAK EXPIRATORY FLOW; PILOT STUDY; RESPIRATORY TRACT INFLAMMATION; SCORING SYSTEM; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT; VIRUS INFECTION; VIRUS REPLICATION; ADULT; AGED; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RHINOVIRUS; VIROLOGY;

ADULT; AGED; COMMON COLD; HUMANS; MIDDLE AGED; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHINOVIRUS;

EID: 33749184326     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-116     Document Type: Article

References (34)

1. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.[comment]. Lancet 1997, 349:1498-1504.
2. National Institute for Clinical Excellence (NICE).: Chronic obstractive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004, 59 (Suppl I).
3. MacNee W, Calverley PM: Chronic obstructive pulmonary disease. 7: Management of COPD.[see comment]. [Review] [99 refs]. Thorax 2003, 58:261-265.
4. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine 1987, 106:196-204.
5. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA: Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. [see comments.]. American Journal of Respiratory & Critical Care Medicine 2001, 164:1618-1623.
6. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G: Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003, 58:37-42.
7. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. American Journal of Respiratory & Critical Care Medicine 2006, 173:1114-1121.
8. Cameron RJ, de Wit D, Welsh TN, Ferguson J, Grissell TV, Rye PJ: Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Medicine 2006, 32:1022-1029.
9. Grunberg K, Sharon RF, Sont JK, In V, Van Schadewijk WA, de Klerk EP, Dick CR, Van Krieken JH, Sterk PJ: Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. American Journal of Respiratory & Critical Care Medicine 2001, 164:1816-1822.
10. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST: Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. American Journal of Respiratory & Critical Care Medicine 1995, 151:879-886.
11. Lemanske RFJ, Dick EC, Swenson CA, Vrtis RF, Busse WW: Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. Journal of Clinical Investigation 1989, 83:1-10.
12. Bardin PG, Fraenkel DJ, Sanderson G, van Schalkwyk EM, Holgate ST, Johnston SL: Peak expiratory flow changes during experimental rhinovirus infection. European Respiratory Journal 2000, 16:980-985.
13. Calhoun WJ, Dick EC, Schwartz LB, Busse WW: A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. Journal of Clinical Investigation 1994, 94:2200-2208.
14. Seymour ML, Gilby N, Bardin PG, Fraenkel DJ, Sanderson G, Penrose JF, Holgate ST, Johnston SL, Sampson AP: Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. Journal of Infectious Diseases 2002, 185:540-544.
15. Turner RB, Wecker MT, Pohl G, Witek TJ, McNally E, St George R, Winther B, Hayden FG: Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA 1999, 281:1797-1804.
16. Hayden FG, Herrington DT, Coats TL, Kim K, Cooper EC, Villano SA, Liu S, Hudson S, Pevear DC, Collett M, McKinlay M, Group. PRIS: Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clinical Infectious Diseases 2003, 36:1523-1532.
17. GG J, HF D, IG S, AV B: Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. Archives of Internal Medicine 1958, 101:267-278.
18. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 1998, 157:1418-1422.
19. Burge S, Wedzicha JA: COPD exacerbations: definitions and classifications. European Respiratory Journal - Supplement 2003, 41:46s-53s.
20. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C, TRial of Inhaled STeroids ANd long-acting beta: Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.[comment][erratum appears in Lancet. 2003 May 10;361(9369):1660]. Lancet 2003, 361:449-456.
21. Bardin PG, Fraenkel DJ, Sanderson G, Dorward M, Lau LC, Johnston SL, Holgate ST: Amplified rhinovirus colds in atopic subjects. Clinical & Experimental Allergy 1994, 24:457-464.
22. Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists.[comment]. Respiratory Medicine 1994, 88:165-194.
23. S.LJ, Tyrrell DA: Rhinoviruses. In Diagnostic procedures for viral, rickettsial and chlamydial infections Edited by: Lennette EH, Schmidt NJ (ed). American Public Health Association, Washington DC; 1995:553-563.
24. Chauhan AJ, S.LJ: Advances in the diagnosis of respiratory virus infections. Skoner DP (ed) Asthma and Respiratory Infections Marcel Dekker, Inc, New York 2001 2003:221-244.
25. Papadopoulos NG, Hunter J, Sanderson G, Meyer J, Johnston SL: Rhinovirus identification by BglI digestion of picornavirus RTPCR amplicons. Journal of Virological Methods 1999, 80:179-185.
26. Maertzdorf J, Wang CK, Brown JB, Quinto JD, Chu M, de Graaf M, van den Hoogen BG, Spaete R, Osterhaus AD, Fouchier RA: Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. Journal of Clinical Microbiology 2004, 42:981-986.
27. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE: Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. Journal of Clinical Investigation 1998, 101:643-649.
28. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA: Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 2000, 161:1608-1613.
29. Calverley P, Pauwels DR, Lofdahl CG, Svensson K, Higenbottam T, Carlsson LG, Stahl E: Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. European Respiratory Journal 2005, 26:406-413.
30. Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA: Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease.[see comment]. American Journal of Respiratory & Critical Care Medicine 2004, 169:1298-1303.
31. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE: Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. Journal of Experimental Medicine 2005, 201:937-947.
32. Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, Johnston SL: Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002, 359:831-834.
33. Couch RB, Cate TR, Douglas RGJ, Gerone PJ, Knight V: Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriological Reviews 1966, 30:517-531.
34. Hall CB, Douglas RGJ, Schnabel KC, Geiman JM: Infectivity of respiratory syncytial virus by various routes of inoculation. Infection & Immunity 1981, 33:779-783.